A detailed history of Kb Financial Partners, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Kb Financial Partners, LLC holds 397 shares of EXAS stock, worth $21,005. This represents 0.01% of its overall portfolio holdings.

Number of Shares
397
Previous 344 15.41%
Holding current value
$21,005
Previous $32,000 15.63%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$65.94 - $99.04 $3,494 - $5,249
53 Added 15.41%
397 $27,000
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $21,561 - $32,697
344 New
344 $32,000
Q2 2021

Aug 17, 2021

SELL
$93.66 - $139.27 $15,172 - $22,561
-162 Closed
0 $0
Q1 2021

Jun 08, 2021

BUY
$116.57 - $155.01 $18,884 - $25,111
162 New
162 $21,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.